STOCK TITAN

Goodness Growth Holdings to Report Third Quarter Results on November 14, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Goodness Growth Holdings, a cannabis company (CSE: GDNS; OTCQX: GDNSF), will report its financial results for Q3 on November 14, 2022, after market close. The company will host a conference call on November 15, 2022, at 8:30 AM ET to discuss the results. Goodness Growth is focused on developing cannabis products and operates in five markets with 18 dispensaries. The company emphasizes sustainable practices and scientific innovation in its product development.

Positive
  • Operating in five markets with 18 dispensaries enhances market reach.
  • Focus on scientific innovation and sustainable practices could lead to improved product differentiation.
Negative
  • None.

MINNEAPOLIS , Nov. 10, 2022 /PRNewswire/ -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP developer, today announced that it will report financial results for its third quarter ended September 30, 2022 on Monday, November 14, 2022 after the market closes.

Goodness Growth management will host a conference call with the investment community the next day, Tuesday, November 15, 2022 at 8:30 a.m. ET (7:30 a.m. CT) to discuss its third-quarter results. Interested parties may attend the conference call by dialing 1-888-660-6217 (Toll-Free) (US and Canada) or 1-929-203-1990 (Toll) (International) and referencing conference ID number 2214400.

A live audio webcast of this event will also be available in the Events & Presentations section of the Company's Investor Relations website and via the following link:
https://events.q4inc.com/attendee/270373966.

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc., is a physician-led, science-focused holding company whose mission is to bring the power of plants to the world. The Company's operations consist primarily of its multi-state cannabis company subsidiary, Vireo Health, Inc., and its science and intellectual property incubator, Resurgent Biosciences, Inc. The Company manufactures proprietary, branded cannabis products in environmentally friendly facilities and state-of-the-art cultivation sites, and distributes its products through its growing network of Green Goods® and other retail locations and third-party dispensaries. Its team of more than 450 employees are focused on the development of differentiated products, driving scientific innovation of plant-based medicines and developing meaningful intellectual property. Today, the Company is licensed to grow, process, and/or distribute cannabis in five markets and operates 18 dispensaries across the United States. For more information about Goodness Growth Holdings, please visit www.goodnessgrowth.com.

Contact Information

Investor Inquiries:

Media Inquiries:

Sam Gibbons

Amanda Hutcheson

Vice President, Investor Relations

Corporate Communications

samgibbons@goodnessgrowth.com

amandahutcheson@goodnessgrowth.com

(612) 314-8995

(919) 815-1476

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/goodness-growth-holdings-to-report-third-quarter-results-on-november-14-2022-301675089.html

SOURCE Goodness Growth Holdings, Inc.

FAQ

When will Goodness Growth Holdings report third quarter results for 2022?

Goodness Growth Holdings will report its third quarter results on November 14, 2022.

What time is the conference call for Goodness Growth Holdings Q3 results?

The conference call will be held on November 15, 2022, at 8:30 AM ET.

What stock symbols are associated with Goodness Growth Holdings?

Goodness Growth Holdings is traded under the symbols GDNS on CSE and GDNSF on OTCQX.

How many dispensaries does Goodness Growth Holdings operate?

Goodness Growth Holdings operates 18 dispensaries across five markets.

What is the focus of Goodness Growth Holdings?

Goodness Growth Holdings focuses on developing cannabis products through scientific innovation and sustainable practices.

GOODNESS GROWTH HLDGS INC

OTC:GDNSF

GDNSF Rankings

GDNSF Latest News

GDNSF Stock Data

61.05M
Pharmaceutical Preparation Manufacturing
Manufacturing
United States of America
Vancouver